Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
Saved in:
Published in | Blood Vol. 140; no. Supplement 1; pp. 4586 - 4587 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
15.11.2022
|
Online Access | Get full text |
ISSN | 0006-4971 1528-0020 |
DOI | 10.1182/blood-2022-166994 |
Cover
ISSN: | 0006-4971 1528-0020 |
---|---|
DOI: | 10.1182/blood-2022-166994 |